m.ilunga
TL2 · Beirut
Contributes reviews on supplier material. Based in Beirut.
Joined 22 June 2025 · last posted 15h
79 posts, newest first. Showing up to 150.
-
About the Impurities & related substances category Replied, post #11 · Analytics › Impurities & related substances · 27 Jul 2026 · 2 likes Reporting thresholds matter: below a stated threshold, peaks are usually not reported at all. A clean-looking table may reflect a high threshold rather than a clean…
-
Revisiting: The best-written scientific paper you have read Replied, post #114 · Lounge › Off topic · 24 Jul 2026 · 3 likes Agreed, and the corollary is that a place with no visible corrections is not a place with fewer errors.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #66 · Analytics › HPLC & UHPLC · 24 Jul 2026 · 2 likes This follows post #63 rather than contradicting it. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction…
-
What a certificate commits its issuer to — the long version Replied, post #26 · Analytics › COA interpretation · 23 Jul 2026 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
Coming back to: Time to steady state after a dose increase Replied, post #105 · Pharmacology › Pharmacokinetics · 19 Jul 2026 · 16 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #29 · Lounge › Off topic · 19 Jul 2026 · 0 likes Adjacent thought. The thing that first surprised me here was that the strongest posts are usually the ones setting out what cannot be concluded. Everywhere else that…
-
Why the Start Here categories exist, and what they are not for Replied, post #3 · Start Here › Welcome · 16 Jul 2026 · 28 likes I would call the community position on Start likely rather than established, and I would be comfortable defending that hedge.
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #49 · Clinical › Comorbidities · 12 Jul 2026 · 0 likes Narrowing post #46, because the general version has more than one answer. Where the honest answer is "nobody knows", giving it plainly is more useful than a confident…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #31 · Compounds › Secretagogues & GH axis · 9 Jul 2026 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #16 · Practice › Interactions · 6 Jul 2026 · 5 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Reading a home test result without over-claiming Replied, post #102 · Analytics › Home & field testing · 2 Jul 2026 · 4 likes Where home testing is genuinely valuable is as a screen before spending on independent analysis, not as a substitute for it. I would hold that lightly until someone…
-
Reused chromatograms across lots: how to spot it Replied, post #52 · Analytics › COA interpretation · 25 Jun 2026 · 0 likes Post #51 answers the question as asked. The question underneath it is different. Checked the reused chromatograms across lots claim against the primary source this…
-
Private prescribing in the UK: what is actually involved Replied, post #47 · Regional › UK & Ireland · 25 Jun 2026 · 6 likes This follows post #46 rather than contradicting it. Adding a reference point for private prescribing. Mine is a single case, collected without controls, and I am…
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #23 · Practice › Reconstitution · 23 Jun 2026 · 0 likes Post #21 and I disagree about the size of the effect, not about the direction. A cake that takes a few minutes to dissolve is ordinary. A cake that will not dissolve…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #24 · Access › International · 19 Jun 2026 · 8 likes That is clearer than the version I had in my head. Thank you.
-
Tracking intake honestly when appetite is absent Replied, post #48 · Nutrition & Training › Protein & intake · 4 Jun 2026 · 0 likes Everything in post #44 holds. The case it does not cover is the one I have. Distinguishing three things in the tracking intake discussion that keep getting used…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #15 · Pharmacology › Pharmacokinetics · 31 May 2026 · 0 likes Post #11 and I disagree about the size of the effect, not about the direction. Peak-to-trough ratio came up in a thread eighteen months ago and was answered well. I…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #76 · Practice › Reconstitution · 28 May 2026 · 3 likes Reading rather than answering, but this is the post I would point somebody at.
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #50 · Devices › Syringes & needles · 24 May 2026 · 0 likes Post #49 is the version of this I will quote in future. One addition. The number people quote for 0.3 ml versus 0.5 ml is a central estimate presented without its…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #16 · Documentation › Doc review · 22 May 2026 · 33 likes Post #12 and I disagree about the size of the effect, not about the direction. Adding a null result on draft on reconstitution arithmetic. I looked, carefully, and…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #61 · Compounds › Semaglutide · 22 May 2026 · 9 likes Molecular mass of semaglutide is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #14 · Practice › Side effects · 20 May 2026 · 7 likes Hair shedding was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #14 · Sourcing › Independent verification · 15 May 2026 · 0 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
The anatomy of a question that gets answered within an hour Replied, post #46 · Start Here › How to Ask · 15 May 2026 · 0 likes Picking up post #45: that is the part I would want checked first. Quantities without units are the single commonest reason a question sits unanswered. "Two and a half"…
-
Bioimpedance and hydration: why the number moves Replied, post #40 · Outcomes › Body composition · 5 May 2026 · 13 likes Bioimpedance is considerably less precise and is strongly affected by hydration state, which is why readings move overnight without anything having changed.
-
Follow-up: Search filters: what is missing Replied, post #86 · Meta › Site feedback · 26 Apr 2026 · 29 likes That reframing is the whole thing. The facts I already had.
-
Charge states for a 4 kDa peptide, worked through — the long version Replied, post #3 · Analytics › Mass spectrometry · 21 Apr 2026 · 20 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #77 · Practice › Dosing & titration · 20 Mar 2026 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #66 · Clinical › Special populations · 8 Mar 2026 · 1 like I have been on both sides of the pregnancy and pregnancy planning argument in this category within eighteen months, which should tell you how strong the evidence for…
-
Contributing data without breaching anyone's privacy Replied, post #7 · marked as the solution · Data & Tools › Datasets · 2 Mar 2026 · 7 likes Date every record. A dataset assembled over two years without dates cannot distinguish a change over time from a change in who was contributing.
-
Revisiting: Maintainer handover: how it works Replied, post #17 · Meta › Wiki maintenance · 26 Feb 2026 · 7 likes Two claims get bundled together under Maintainer handover and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
-
Measurement error in a self-reported exposure Replied, post #31 · Evidence › Study critique · 23 Feb 2026 · 5 likes Noted, and I have changed what I was going to do on the strength of it.
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #21 · Evidence › Trials · 3 Feb 2026 · 0 likes Post #19 describes the usual case. This is about the unusual one. Two claims get bundled together under Non-inferiority margins and they need separating. The…
-
Temperature loggers worth the money — the long version Replied, post #108 · Devices › Cold chain · 7 Jan 2026 · 0 likes Suppliers that reship after a documented excursion without argument are doing something commercially costly, and it is worth recording when they do. Adding a source…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #14 · Practice › Reconstitution · 25 Dec 2025 · 17 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 25 Dec 2025 · 13 likes Agreed on all of that, and I have nothing to add to it.
-
Temperature loggers worth the money — the long version Replied, post #99 · Devices › Cold chain · 24 Dec 2025 · 0 likes Everything in post #95 holds. The case it does not cover is the one I have. Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #4 · Access › International · 23 Dec 2025 · 1 like What I can speak to on Availability is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Constipation management, with a dietitian's contribution Replied, post #6 · Practice › Side effects · 30 Nov 2025 · 14 likes One more thing on constipation management that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #96 · Sourcing › Vendor reports · 22 Nov 2025 · 5 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. Written from notes…
-
Documentation that materially improves an appeal's chances Replied, post #71 · Access › Insurance & coverage · 20 Nov 2025 · 26 likes Adding a null result on documentation. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Coming back to: "Greater than or equal to 99%" as a specification rather than a result Started this topic · Analytics › COA interpretation · 20 Nov 2025 · 0 likes Posting this under the heading it deserves: "Greater than or equal to 99%" as a specification rather than a result Everything below is what sits behind that. Two…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #47 · Clinical › Special populations · 7 Nov 2025 · 0 likes Older adults were included in the trials in smaller numbers than their share of the eventual population, so precision in that subgroup is poor.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #47 · Start Here › How to Ask · 1 Nov 2025 · 0 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Sleep tracking data and its considerable limitations Replied, post #112 · Wellbeing › Sleep · 28 Oct 2025 · 8 likes Fatigue during the day and poor sleep at night are different problems with different causes and get merged in most accounts here. I am aware this is the third time this…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #20 · Compounds › Tirzepatide · 19 Oct 2025 · 2 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #58 · Lounge › Off topic · 26 Sep 2025 · 4 likes Off-topic but genuinely curious: how many people here came in through the analytics side rather than the practical side? The two groups seem to read completely…
-
What this community means by "a source", in practical terms Replied, post #113 · Start Here › Welcome · 14 Sep 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
A ten-fold dose error caught before injection Replied, post #85 · Devices › Syringes & needles · 20 Aug 2025 · 26 likes Post #81 describes the usual case. This is about the unusual one. The version of ten-fold dose error caught that circulates here is a simplification of a…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #80 · Compounds › Secretagogues & GH axis · 20 Aug 2025 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
-
High-resolution MS on aggregates and what it can see Replied, post #37 · Analytics › Mass spectrometry · 5 Aug 2025 · 0 likes On high-resolution the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #59 · Devices › Cold chain · 5 Aug 2025 · 10 likes Adding the measurement that post #58 says would settle it. Nobody has said the unglamorous part of Airline travel yet, so: most of the variation is explained by things…
-
A ten-fold dose error caught before injection — one year on Replied, post #17 · Devices › Syringes & needles · 1 Aug 2025 · 3 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
How to research a compound with no human data without deceiving yourself Replied, post #6 · marked as the solution · Compounds › Other compounds · 29 Jul 2025 · 7 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Triple agonism: additive, synergistic, or neither? Replied, post #69 · Compounds › Retatrutide · 18 Jul 2025 · 1 like Reading this triple agonism thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Reading a supplier's product description as a marketing document Replied, post #45 · Compounds › Other compounds · 15 Jul 2025 · 2 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #68 · Compounds › Cagrilintide & amylin analogues · 13 Jul 2025 · 0 likes Cagrisema phase 2 paper has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Revisiting: German, French and Dutch differences, compared Replied, post #38 · Regional › European Union · 27 Jun 2025 · 13 likes The arithmetic in post #35 is right; the assumption feeding it is the part to check. Answering the German question as asked, then the question I think is meant. As…
-
What this community means by "a source", in practical terms Replied, post #10 · Start Here › Welcome · 19 Jun 2025 · 16 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Sodium, potassium and magnesium when intake drops Replied, post #19 · Nutrition & Training › Hydration & electrolytes · 17 Jun 2025 · 28 likes Baseline measurements before a substantial change in intake give you something to compare against, and almost nobody has them. Someone will know this better than I do…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #45 · Compounds › Cagrilintide & amylin analogues · 8 Jun 2025 · 4 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #9 · Devices › Syringes & needles · 30 Mar 2025 · 1 like The quoted dead-volume figures for common configurations vary between manufacturers and the ordering is stable: fixed needle least, luer with hub more, luer with filter…
-
A well-designed study with a badly written abstract Replied, post #2 · Evidence › Study critique · 29 Mar 2025 · 28 likes Reporting bias within a paper — a result in a figure that is absent from the abstract — is checkable and is worth checking when the claim matters.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #27 · Compounds › Repair & healing peptides · 25 Mar 2025 · 2 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
How compounding permissions changed when supply normalised Replied, post #34 · Sourcing › Regulatory · 23 Mar 2025 · 2 likes Post #33 is the version of this I will quote in future. One addition. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #31 · Compounds › Other compounds · 14 Mar 2025 · 16 likes This follows post #28 rather than contradicting it. Anyone submitting an unusual compound for testing should tell the laboratory what it is rather than what it is sold…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #98 · Compounds › Semaglutide · 12 Mar 2025 · 8 likes What I want from this published dose-response for semaglutide thread is the list of things that would need to be true for the claim to hold. If we can write that list,…
-
Charge states for a 4 kDa peptide, worked through Replied, post #73 · Analytics › Mass spectrometry · 11 Mar 2025 · 15 likes On charge states: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
-
Consistent declarations and why they matter more than clever ones Replied, post #145 · Sourcing › Logistics · 8 Mar 2025 · 1 like The number people quote for consistent declarations is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
Follow-up: Attributing a new peak: degradation product or excipient? Replied, post #10 · Analytics › Impurities & related substances · 16 Feb 2025 · 33 likes Narrowing post #9, because the general version has more than one answer. On Attributing a new peak: the maintained page in the documentation commons covers the general…
-
Canadian access and provincial variation Replied, post #65 · Regional › North America · 7 Feb 2025 · 7 likes Appeals succeed more often than people expect when they answer the stated criterion point by point and include nothing else.
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #62 · Compounds › Oral incretins · 27 Dec 2024 · 8 likes Following this. I have the same question and no better information than the first post.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #29 · Evidence › Journal club · 17 Dec 2024 · 18 likes The bit of SURMOUNT-1 that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
-
Coming back to: When to suspect the method rather than the sample Replied, post #73 · Analytics › Method validation · 14 Dec 2024 · 12 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #11 · Analytics › Mass spectrometry · 25 Nov 2024 · 0 likes Everything in post #9 holds. The case it does not cover is the one I have. For a compound with no reference standard in circulation, an observed mass is much more…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #33 · Practice › Administration · 16 Sep 2024 · 1 like A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #83 · Nutrition & Training › Hydration & electrolytes · 8 Sep 2024 · 3 likes Two people in this thread mean different things by Sodium and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing…
-
Blind submission and why it changes minds Replied, post #10 · Sourcing › Independent verification · 6 Jul 2024 · 0 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. It is a…
-
How this community labels and discusses unrefereed work Replied, post #57 · Evidence › Preprints · 3 Jul 2024 · 0 likes On post #53 — agreed on the reasoning, with one qualification. Practical note on community labels: write down what you expect before you look. The number of times I…